Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/8882
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRajabto, Wulyo-
dc.contributor.authorSingh, Gurmeet-
dc.contributor.authorMulyadi, Calvin Kurnia-
dc.contributor.authorChandika, Vitya-
dc.contributor.authorPyrhadistya, Maria-
dc.date.accessioned2024-12-13T02:26:18Z-
dc.date.available2024-12-13T02:26:18Z-
dc.date.issued2024-01-
dc.identifier.citationOriginal Articleen_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/8882-
dc.description.abstractBackground: Numerous studies explored the association between anemia and mortality in patients with severe pneumonia due to COVID-19. However, the findings were inconsistent. Therefore, this study was conducted to investigate the association between anemia at HCU admission and in-hospital mortality in severe pneumonia COVID-19 patients. Methods: This retrospective cohort study obtained data on 110 COVID-19 patients with severe pneumonia who were admitted to the HCU between January, 1st 2021, and May 31st, 2021. Patients were categorized as anemic and non-anemic based on the World Health Organization (WHO) guidelines. The demographic and clinical characteristics of the subjects were described. The Chi-squared test was carried out followed by a logistic regression test to determine the association of anemia and mortality. Results: Anemia was observed in 31% of 110 patients with severe pneumonia COVID-19. The source population consisted of 60.9% men and 39.1% women with a median age of 58 years. The most prevalent comorbidity was hypertension (38.2%), followed by diabetes mellitus (27.2%), renal diseases (19.1%) and heart diseases (10%). TAnemia on HCU admission was associated with in-hospital mortality in patients with severe pneumonia COVID-19 (RR: 2.794, 95% CI 1.470-5.312). After adjusting comorbidities as confounding factors, anemia was independently associated with mortality (RR: 2.204, 95% CI: 1.124-4.323, P < 0.021). The result also showed anemic patients had longer lengths of stay and higher levels of D-dimer than non-anemic patients. The median duration length of stay among the anemic and non-anemic was 16 (11-22) and 13 (9-17) days, respectively. The median D-dimer among the anemic and non-anemic was 2220 μg/ml and 1010 μg/ml, respectively. Conclusion: There is a significant association between anemia at HCU admission and mortality in patients with severe pneumonia COVID-19 during hospitalization.en_US
dc.language.isoen_USen_US
dc.publisherActa Medica Indosianaen_US
dc.subjectAnemiaen_US
dc.subjectMortalityen_US
dc.subjectSevere Pneumonia COVID-19en_US
dc.subjectRetrospective Cohorten_US
dc.titleThe Association between Anemia and Mortality of Severe Pneumonia COVID-19 Patients in the High Care Unit of a Tertiary Hospital in Jakartaen_US
dc.typeArticleen_US
Appears in Collections:VOL 56 NO 1 2024

Files in This Item:
File Description SizeFormat 
63-68.pdf446.76 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.